TCPWM
Traverso Chambers Private Wealth Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,357
| Closed | -$166K | – | 124 |
|
|
2023
Q3 | $166K | Hold |
10,357
| – | – | 0.04% | 113 |
|
|
2023
Q2 | $240K | Hold |
10,357
| – | – | 0.06% | 104 |
|
|
2023
Q1 | $241K | Hold |
10,357
| – | – | 0.07% | 103 |
|
|
2022
Q4 | $150K | Hold |
10,357
| – | – | 0.04% | 107 |
|
|
2022
Q3 | $198K | Hold |
10,357
| – | – | 0.06% | 109 |
|
|
2022
Q2 | $188K | Hold |
10,357
| – | – | 0.06% | 104 |
|
|
2022
Q1 | $261K | Hold |
10,357
| – | – | 0.08% | 103 |
|
|
2021
Q4 | $286K | Hold |
10,357
| – | – | 0.08% | 97 |
|
|
2021
Q3 | $334K | Hold |
10,357
| – | – | 0.1% | 89 |
|
|
2021
Q2 | $317K | Hold |
10,357
| – | – | 0.1% | 91 |
|
|
2021
Q1 | $315K | Sell |
10,357
-6,500
| -39% | -$198K | 0.11% | 83 |
|
|
2020
Q4 | $333K | Hold |
16,857
| – | – | 0.12% | 79 |
|
|
2020
Q3 | $220K | Hold |
16,857
| – | – | 0.09% | 95 |
|
|
2020
Q2 | $191K | Hold |
16,857
| – | – | 0.08% | 95 |
|
|
2020
Q1 | $241K | Buy |
16,857
+5,000
| +42% | +$71.5K | 0.11% | 81 |
|
|
2019
Q4 | $323K | Buy |
+11,857
| New | +$323K | 0.14% | 77 |
|